肝脏恶性肿瘤

  • 网络hepatocellular carcinoma;malignant tumor of liver
肝脏恶性肿瘤肝脏恶性肿瘤
  1. MR全肝灌注成像对肝脏恶性肿瘤的实验及临床应用研究

    Whole Liver MR Perfusion Imaging : Experiment and Clinical Study on Malignant Tumor

  2. CT导向经皮穿刺热盐水注射治疗肝脏恶性肿瘤15例

    Percutaneous Hot Saline Injection Therapy by CT Guide for Hepatic Malignant Tumor

  3. 肝细胞肝癌(Hepatocellularcarcinoma,HCC)是最常见的肝脏恶性肿瘤,是世界范围内主要的健康问题之一。

    Hepatocellular carcinoma ( HCC ) is the most common liver malignancy and a major health problem globally .

  4. 肝脏恶性肿瘤扩散加权成像与T2加权成像对比研究

    Comparison of diffusion-weighted imaging and T2-weighted imaging in hepatic malignant tumors

  5. 目的分析氩氦刀冷冻和射频治疗肝脏恶性肿瘤的CT表现,探讨其与疗效的关系。

    Objective : To study the characteristics of CT image of the patients with hepatic carcinoma treated with Ar-He cryoablation or RF and assess the relationship between the treatment and the efficacy .

  6. 目的探讨CT引导下肝脏恶性肿瘤经皮穿刺酒精注射(PEI)治疗的技术及临床价值。

    Objective To investigate the technical points of CT-guided percutaneous ethanol injection ( PEI ) and its clinical value in the treatment of hepatic neoplasm .

  7. 原发性肝脏恶性肿瘤主要有肝细胞癌(Hepatocellularcarcinoma,HCC)和胆管细胞癌,而前者的发病率约为后者的十倍。

    There are two kinds of primary malignant liver tumours , hepatocellular carcinoma ( HCC ) and cholangiocarcinoma . Hepatocellular carcinoma is 10 times more frequent than cholangiocarcinoma .

  8. 方法对35例CT引导下冷循环射频消融术的肝脏恶性肿瘤患者进行全面细致的护理,包括术前给予健康教育、术中配合适当的护理、术后加强并发症护理和心理护理。

    Methods 35 patients with hepatic carcinoma treated by cool-tip radiofrequency ablation were given health education and psychological nursing before operation , illness state and careful cooperation during operation and corresponding nursing after operation .

  9. 目的探讨全身热疗法(wholebodyhyperthermia,WBH)治疗肝脏恶性肿瘤的疗效及其对肝功能的影响。

    Objective To evaluate the efficacy of whole body hyperthermia ( WBH ) in the treatment of advanced hepatic carcinoma and its effect on liver function .

  10. 目的研究小儿原发性肝脏恶性肿瘤中血管内皮生长因子(VEGF)和微血管密度(MVD)的特点。

    Objective To study the features of vascular endothelial growth factor ( VEGF ) expression and microvascular densities ( MVD ) count in pediatric malignant liver tumors .

  11. 以COX风险比例回归方法为媒介,筛选影响本中心肝移植受体术后存活的因素,并分别构建良性肝病与肝脏恶性肿瘤患者的术后评估模型;

    Cox proportional-hazards regression was the main tool for screening risk factors affecting the posttransplant survival , and respectively establishing evaluation model for benign and malignant liver disease .

  12. 采用传统分型分期与组织亚型及TNM分期对10例小儿肝脏恶性肿瘤的治疗方法与疗效评估进行对比研究。

    The therapeutic effectiveness of 10 cases of malignant hepatoma in children were evaluated with traditional typing and staging histologic subtyping and TNM staging .

  13. 目的探讨射频消融(radiofrequencyablationRFA)治疗肝脏恶性肿瘤的可行性和安全性及初步治疗效果、不良反应。

    Objective Probe into the radio frequency and melt ( radiofrequency ablation RFA ) Treat the preliminary therapeutic effect of liver malignant tumour , security of the bad reaction and RFA .

  14. 目的:探讨经皮射频消融(PRFA)对肝脏恶性肿瘤的治疗效果。

    Purpose : To evaluate the efficacy of percutaneous cluster electrode radiofrequency ablation ( PRFA ) to treat liver cancer .

  15. 背景与目的:肝内胆管囊腺癌(intrahepaticbiliarycystadenocarcinoma)是一种罕见的肝脏恶性肿瘤,临床资料较少,诊断和治疗缺乏经验。

    BACKGROUND & OBJECTIVE : Intrahepatic biliary cystadenocarcinoma ( IBC ) is a rare intrahepatic malignant tumor which is scarcely reported , and there is relatively little experience in the diagnosis and treatment .

  16. 经皮肝穿刺射频热凝治疗肝脏恶性肿瘤(英文)目的评价经皮射频(PRFA)治疗肝脏恶性肿瘤的效果、安全性和价值。

    Objective : To assess the local treatment efficacy and safety of percutaneous radiofrequency ablation ( PRFA ) therapy for hepatic malignancies .

  17. 方法采用APAAP法测定65例肝脏恶性肿瘤患者治疗前、后及治疗后2个月T淋巴细胞亚群数值。

    Methods The T lymphocyte subsets were determined by APAAP method before therapy , after therapy and two months after therapy in 65 cases of liver malignant tumors .

  18. 方法对220例因肝脏恶性肿瘤做首次TACE的患者进行了系统护理监测,观察TACE术中心电图、血压和呼吸等生命体征变化发生的频次,分析术中影响生命体征变化的因素。

    Methods Systematically , monitoring of the vital signs was performed in 220 patients with hepatic malignant tumors during their first TACE procedures . Such vital signs as ECG , blood pressure and respiration were observed and the factors affecting vital signs were analyzed .

  19. 结果①WBH治疗不能手术切除的晚期肝脏恶性肿瘤患者的有效率为61.5%(24/39),60.0%(9/15)的患者AFP有不同程度下降,肿瘤疼痛缓解率达100%;

    Results ① The effective rate of WBH was 61.5 % ( 24 / 39 ) in the treatment of advanced hepatic carcinoma with declined AFP in 60.0 % ( 9 / 15 ) of patient and 100 % of patients had pain relieve .

  20. 射频联合无水酒精注射治疗肝脏恶性肿瘤

    Percutaneous radiofrequency ablation combined with ethanol injection to treat liver malignancies

  21. 肝脏恶性肿瘤术后隔下感染的病因探讨

    The etiology study on subphrenic infection after hepatectomy for malignancy patients

  22. 彩超监测1200例肾移植术后并发肝脏恶性肿瘤

    CDFI diagnosis of kidney transplantation associated with 1200 malignant hepatic tumor

  23. 继发性肝脏恶性肿瘤的处理继发性肝癌35例。

    Treatment of Secondary Metastatic Hepatocarcinoma 35 with secondary liver tumors .

  24. 经皮射频治疗肝脏恶性肿瘤114例临床分析

    Percutaneous radiofrequency ablation therapy for hepatic malignancies in 114 patients

  25. 经皮射频热切除术治疗肝脏恶性肿瘤

    Treatment of liver malignant tumor by percutaneous radiofrequency thermal abation

  26. 影像技术导引下肝脏恶性肿瘤的微创治疗新进展

    New Development of Minimally Invasive Treatment of Liver Malignant Tumors

  27. 小儿原发性肝脏恶性肿瘤的病理及临床特点

    Pathological and Clinical Characters of Primary Malignant Tumors of Liver in Children

  28. 全身热疗法治疗晚期肝脏恶性肿瘤39例报告

    Whole Body Hyperthermia in Treatment of 39 Cases of Advanced Hepatic Carcinoma

  29. 中晚期原发性肝脏恶性肿瘤166例临床分析

    166 cases of primary malignant liver neoplasms in middle and later stage

  30. 小儿肝脏恶性肿瘤分型分期和治疗方法评价

    The typing and staging of malignant hepatoma in children and its treatment